| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.700 | None | 0.966 | 178 | 7 | 1983 | 2019 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.500 | None | 0.968 | 154 | 4 | 1988 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.500 | None | 0.912 | 114 | 9 | 1991 | 2019 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.500 | None | 0.960 | 99 | 4 | 1986 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.500 | None | 0.967 | 91 | 11 | 1986 | 2020 | ||||||||
|
phospholipase A2 group VII | 0.537 | 0.769 | 5.3E-22 |
|
disease | 0.500 | None | 0.975 | 40 | 6 | 1997 | 2019 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
disease | 0.470 | None | 1.000 | 10 | 3 | 1998 | 2017 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.450 | None | 1.000 | 8 | 3 | 2008 | 2019 | ||||||||
|
zinc finger C3HC-type containing 1 | 0.760 | 0.308 | 2.6E-04 |
|
disease | 0.440 | None | 1.000 | 9 | 1 | 2011 | 2019 | ||||||||
|
ATP binding cassette subfamily G member 5 | 0.592 | 0.577 | 3.1E-21 |
|
disease | 0.420 | None | 1.000 | 4 | 2 | 2009 | 2018 | ||||||||
|
dynein axonemal heavy chain 11 | 0.587 | 0.692 | 2.5E-58 |
|
disease | 0.410 | None | 1.000 | 3 | 1 | 2009 | 2019 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 0.920 | 174 | 4 | 1992 | 2020 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.400 | None | 0.938 | 96 | 5 | 1996 | 2019 | ||||||||
|
lipoprotein lipase | 0.474 | 0.808 | 1.3E-09 |
|
disease | 0.400 | None | 0.987 | 78 | 7 | 1993 | 2020 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.400 | None | 0.923 | 13 | 2 | 1996 | 2019 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
disease | 0.400 | None | 1.000 | 13 | 5 | 1998 | 2019 | ||||||||
|
C-X3-C motif chemokine receptor 1 | 0.457 | 0.885 | 6.1E-02 |
|
disease | 0.400 | None | 1.000 | 10 | 2 | 2001 | 2016 | ||||||||
|
muscle RAS oncogene homolog | 0.590 | 0.731 | 0.92 |
|
disease | 0.400 | None | 1.000 | 5 | 2 | 2009 | 2017 | ||||||||
|
insulin receptor substrate 1 | 0.488 | 0.769 | 2.4E-02 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 1999 | 2019 | ||||||||
|
vitamin K epoxide reductase complex subunit 1 | 0.603 | 0.731 | 0.16 |
|
disease | 0.340 | None | 1.000 | 4 | 1 | 2006 | 2013 | ||||||||
|
coiled-coil domain containing 92 | 0.839 | 0.154 | 0.30 |
|
disease | 0.330 | None | 1.000 | 3 | 1 | 2017 | 2018 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.310 | None | 1.000 | 3 | 1 | 1992 | 2014 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.310 | None | 1.000 | 2 | 1 | 2008 | 2008 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.300 | None | 0.971 | 34 | 2 | 2002 | 2019 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.300 | None | 0.941 | 17 | 0 | 2002 | 2020 |